Table 2.
Characteristic | Hospitalized (n=380) | ICUb admission (n=60) | Death (n=44) | ||||
COVID-19 positive, n/N (%)c | 380/900 (42.2) | 60/69 (86.96) | 44/107 (41.1) | ||||
Sex, n (%) | |||||||
|
Male | 244 (64.2) | 45 (0.75) | 30 (68.2) | |||
|
Female | 136 (35.8) | 15 (0.25) | 14 (31.8) | |||
Age (years), median (IQR) | 69.5 (55-80) | 63.0 (54-71) | 78 (70-85) | ||||
Age group (years), n (%) | |||||||
|
<21 | 4 (1.1) | 0 (0) | 0 (0) | |||
|
21-40 | 57 (15) | 4 (6.7) | 0 (0) | |||
|
41-60 | 104 (27.4) | 20 (33.3) | 3 (5) | |||
|
61-80 | 179 (47.1) | 35 (58.3) | 26 (59.1) | |||
|
81+ | 36 (9.5) | 1 (1.7) | 15 (34.1) | |||
Symptoms, n (%) | |||||||
|
Altered taste | 13 (3.4) | 0 (0) | 0 (0) | |||
|
Anosmia | 25 (6.6) | 3 (5) | 2 (4.5) | |||
|
Cough | 285 (75) | 50 (83.3) | 30 (68.2) | |||
|
Fever | 192 (50.5) | 39 (65) | 18 (40.9) | |||
|
Feverishness | 167 (43.9) | 21 (35) | 21 (47.7) | |||
|
Loss of taste | 24 (6.3) | 1 (1.7) | 1 (2.3) | |||
|
Malaise | 15 (3.9) | 3 (5) | 0 (0) | |||
|
Nausea | 60 (15.8) | 6 (10) | 1 (2.3) | |||
|
Shortness of breath | 263 (69.2) | 47 (78.3) | 30 (68.2) | |||
|
Vomiting | 49 (12.9) | 5 (8.3) | 1 (2.3) | |||
Underlying conditions, n (%) | |||||||
|
Asthma | 32 (8.4) | 4 (6.7) | 4 (9.1) | |||
|
Cancer | 23 (6.1) | 4 (6.7) | 7 (15.9) | |||
|
Chronic heart disease | 68 (17.9) | 11 (18.3) | 22 (50) | |||
|
Chronic lung disease | 12 (3.2) | 1 (1.7) | 4 (9.1) | |||
|
Chronic kidney disease | 21 (5.5) | 6 (10) | 5 (11.4) | |||
|
Diabetes | 98 (25.8) | 22 (36.7) | 14 (31.8) | |||
|
Dyslipidemia | 48 (12.6) | 7 (11.7) | 5 (11.4) | |||
|
Hypertension | 140 (36.8) | 27 (45) | 30 (68.2) | |||
|
Obese | 19 (5) | 8 (13.3) | 4 (9.1) | |||
Clinical conditions, n (%) | |||||||
|
Acute respiratory distress syndrome | 18 (4.7) | 11 (18.3) | 3 (6.8) | |||
|
Pneumonia | 348 (91.6) | 55 (91.7) | 31 (70.5) |
aSARI: severe acute respiratory infections.
bICU: intensive care unit.
cThis row shows row percentages, whereas other rows show column percentages.